Testing for anti-neuromyelitis optica (NMO) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in the serum in two reference laboratories (University Hospital of Zurich, University Hospital of Basel) with different assays was negative. The gene discussed is OMG; the disease is neuromyelitis optica.